This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renzenbrink, G. J Articles by Ijzerman, M. J Search for Related Content PubMed PubMed Citation Articles by Renzenbrink, G. J Articles by Ijzerman, M. J Social Bookmarking                   What's this?

Percutaneous neuromuscular electrical stimulation (P-NMES) for treating shoulder pain in chronic hemiplegia. Effects on shoulder pain and quality of life

Roessingh Research and Development and Rehabilitation centre Het Roessingh, Enschede, The Netherlands

Maarten J Ijzerman

Roessingh Research and Development, Enschede, The Netherlands

Objective: To evaluate the effect of percutaneous neuromuscular electrical stimulation (P-NMES) of the shoulder muscles on shoulder pain intensity and health-related quality of life in chronic hemiplegia.

Design: Prospective, open label design.

Setting: The outpatient services of a large teaching rehabilitation hospital in the Netherlands.

Subjects: Fifteen stroke survivors with chronic (> six months) hemiplegia and a therapy-resistant painful shoulder with subluxation. All patients suffered from clinically relevant shoulder pain, as assessed by a score of at least 4 out of 10 on a numerical rating scale. Shoulder subluxation was indicated by at least 1/2 fingerbreadth of glenohumeral separation on palpation.

Intervention: Six hours of P-NMES per day for a total of six weeks.

Main outcome measures: Shoulder pain (Brief Pain Inventory), shoulder subluxation (clinical and radiographic), shoulder pain-free external rotation (hand-held goniometer), motor impairment (Fugl-Meyer Motor test) and quality of life (SF-36) were assessed before treatment, after six weeks of intramuscular stimulation, at three months and six months follow-up.

Results: A significant reduction in pain was found on the Brief Pain Inventory. Pain reduction was still present at six months follow-up. All domains, in particular bodily pain, of the SF-36 showed improvement in the short term. After six months of follow-up, bodily pain was still strongly and significantly reduced, whereas social functioning and role physical demonstrated a nonsignificant improvement of more than 10% compared with baseline.

Conclusion: This pilot suggests that P-NMES potentially reduces shoulder pain in chronic hemiplegia. To establish the clinical value of P-NMES in treating hemiplegic shoulder pain a randomized controlled trial is needed.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J.-Y. Lim, J.-H. Koh, and N.-J. Paik Intramuscular Botulinum Toxin-A Reduces Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Comparative Study Versus Intraarticular Triamcinolone Acetonide Stroke, January 1, 2008; 39(1): 126 - 131. [Abstract] [Full Text] [PDF]

				J. Chae, A. Ng, D. T. Yu, A. Kirsteins, E. P. Elovic, S. R. Flanagan, R. L. Harvey, R. D. Zorowitz, and Z.-P. Fang Intramuscular Electrical Stimulation for Shoulder Pain in Hemiplegia: Does Time From Stroke Onset Predict Treatment Success? Neurorehabil Neural Repair, December 1, 2007; 21(6): 561 - 567. [Abstract] [PDF]